Stay updated with breaking news from Poster Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Biognosys AG, Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023
In collaboration with prominent biopharma companies and academic institutions, Biognosys will demonstrate the technological advances and versatility of the TrueDiscovery, TrueTarget, and TrueSignature
OBI Pharma Announces Poster Presentations at AACR 2023 Annual Meeting for OBI-999 Combination Synergy with Checkpoint Inhibitor as well as Globo H-targeted CAR T-cell Immunotherapy
Poster Presentations to highlight the latest research on OBI-999's (anti-Globo H ADC) synergistic anti-tumor effect in combination with pembrolizumab and OBI's development of CAR T-cell cancer immunotherapy
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2,... | March 23, 2023